NYSE: IPOX® CEO Josef Schuster Discusses the Importance of IPO Indexing

NYSE featured IPOX® Founder and CEO Dr. Josef Schuster in a video interview following his first opening-bell ceremony at the New York Stock Exchange. The discussion focused on the role of IPO indexing, the development of IPOX®’s approach to tracking newly listed companies, and the market opportunity created by IPOs, spin-offs, de-SPACs, and other new listings.

Dr. Schuster explained that IPOX® pioneered an index-based framework for accessing IPO exposure in the aftermarket, rather than through allocations at the offering. He noted that IPOX® typically tracks newly listed companies over the first four to five years after listing, a period when trading activity, market attention, opportunities, and risks are often elevated.

The interview also highlighted IPOX®’s process-driven, technology-based methodology and the IPOX® 100 U.S. Index, which selects 100 of the largest companies from the broader IPOX® universe on a quarterly basis. Dr. Schuster discussed IPOX®’s 20-year history, its longstanding relationship with First Trust, and the broader product ecosystem tied to IPOX® indexes, including ETFs and CME-traded E-mini futures.

Dr. Schuster also pointed to continued product innovation across pre-IPO and post-IPO markets, noting the growing role of large companies acquiring newly public firms and the broader “growth infusion effect” shaping IPO market behavior.

Read the full article on NYSE: IPOX Schuster CEO Josef Schuster Discusses Importance of ‘IPO Indexing’